当前位置:首页 > 期刊 > 《中国实用医药》 > 2010年第12期 > 正文
编号:13192728
肺表面活性物质治疗早产儿肺透明膜病的护理
http://www.100md.com 2010年4月25日 《中国实用医药》2010年第12期
     【摘要】 目的 探讨肺表面活性物质(PS)在治疗早产儿肺透明膜病(HMD)的临床护理疗效。方法 将肺表面活性物质固尔苏药液200 mg/kg通过气管插管及导管分4次注入气管内,并通过正压通气使之均匀分布于两肺气道。结果 观察患儿用药前后呼吸机参数的变化。10例患儿中,8例痊愈出院,1例好转出院,1例在HMD痊愈后发生败血症、硬肿症(新生儿寒冷损伤综合征)、感染性休克而死亡。结论 应用PS治疗HMD后,对症的护理可明显改善其转归。

    【关键词】

    肺透明膜病;肺表面活性物质;护理

    Nursing effects of treatment of hyaline membrane disease of newborns with pulmonary surfactant CHEN Ai-feng,HU Xiao-wei,PEMH Su-jin.Department of Pediatrics,municipal central hospital of huizhou,Guangdong 516001,China

    【Abstract】 Objective To explore the nursing effects of pulmonary surfactant(PS)on hyaline membrane disease of newborn(HMD).Methods Pulmonary surfactant with a dosage of 200 mg/kg were given to patients four times through tracheal intubation and were distributed evevly in two lungs through mechanical ventilation.Results 8 cases recovered.1 case discharged after improvement and 1 case die of septicemia neonatal cold injure syndrome and septic shock.Conclusion The pulmonary surfactant has good effects on NRDS andintensive nursing could improve the prognosis. ......

您现在查看是摘要页,全文长 5152 字符